Tirzepatide 3 month supply

Tirzepatide 3-Month Weight Loss Program — Up to 160 mg

This 3-month tirzepatide program provides up to 160 mg of tirzepatide for use over approximately 12 weeks, based on the Phoenix Clinical Services treatment protocol and your individualized prescription.

Your program includes monthly telehealth follow-up visits at no additional charge. Patients are required to check in with their Phoenix Clinical Services provider at least once each month to review weight-loss progress, medication tolerance, potential side effects, and any questions or concerns.

Your dose is individualized and may be increased, maintained, decreased, or discontinued based on your response and clinical needs. Not every patient will require or use the full 160 mg. Never increase or change your dose without instructions from your healthcare provider.

Program Includes:• Up to 160 mg of tirzepatide for the 3-month treatment period• Individualized dosing instructions• Monthly telehealth follow-up at no additional charge• Weight and progress monitoring• Side-effect and medication-tolerance review• Provider support throughout the treatment period

Prescription and medical evaluation required. Compounded tirzepatide is not FDA-approved and may differ from FDA-approved tirzepatide products.